The present invention relates to a pharmaceutical composition, and to a food composition, for regulating intestinal motility, and more particularly, to a pharmaceutical composition, and to a food composition, which use a Chamaecyparis obtusa extract so as to be effective in the prevention and treatment of intestinal motility disorders. The pharmaceutical composition for regulating intestinal motility according to the present invention contains the Chamaecyparis obtusa extract as an active ingredient, wherein intestinal motility is regulated by varying the electrical activity of interstitial cells of Cajal. Further, the food composition for regulating intestinal motility according to the present invention contains the Chamaecyparis obtusa extract as an active ingredient.La présente invention concerne une composition pharmaceutique et une composition alimentaire destinées à réguler la motilité intestinale, et plus particulièrement une composition pharmaceutique et une composition alimentaire utilisant un extrait de Chamaecyparis obtusa afin de prévenir et de traiter des troubles de la motilité intestinale de manière efficace. Ladite composition pharmaceutique destinée à la régulation de la motilité intestinale contient l'extrait de Chamaecyparis obtusa en tant que principe actif, la motilité intestinale étant régulée par la variation de l'activité électrique des cellules interstitielles de Cajal. En outre, ladite composition alimentaire destinée à réguler la motilité intestinale contient l'extrait de Chamaecyparis obtusa en tant que principe actif.본 발명은 위장관 운동 조절용 약학 조성물 및 식품 조성물에 관한 것으로서, 더욱 상세하게는 편백 추출물을 이용하여 위장관 운동 장애 질환의 예방 및 치료에 효과적인 약학 조성물 및 식품 조성물에 관한 것이다. 본 발명의 위장관 운동 조절용 약학 조성물은 편백 추출물을 유효성분으로 함유하며, 위장관 운동 조절은 카할간질세포(interstitial cells of Cajal)의 전기적 활동도를 변화시켜 수행된다. 또한, 본 발명의 위장관 운동 조절용 식품 조성물은 편백 추출물을 유효성분으로 함유한다.
